Steven H. Rouhandeh is Director & 10% Owner at ABEONA THERAPEUTICS INC. (ABEO). They have made 8 open-market trades across 3 companies since 2007, most recently 2021-05-25.
CIK 0001294343
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $1.5M since 2007, against 6 sales. Too few scored purchases to measure a record yet.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 100% | 67% | 100% |
| Avg Move | -15.5% | -17.3% | -35.9% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ABEO | SELL | 2021-05-03 | 2021-05-05 | $2.01 | $322K | -15.5% | +5.0% | -23.6% |
| ABEO | SELL | 2021-03-18 | 2021-03-19 | $2.23 | $178K | -13.4% | -35.0% | -21.2% |
| ABEO | SELL | 2021-02-08 | 2021-02-10 | $3.01 | $722K | -39.2% | -32.0% | -62.1% |
| ABEO | SELL | 2021-01-14 | 2021-01-19 | $2.06 | $1.3M | -12.0% | +13.4% | -35.0% |
| ABEO | SELL · 10b5-1 | 2020-09-15 | 2020-09-17 | $2.00 | $4K | -49.5% | -40.5% | -25.9% |
| ABEO | SELL | 2020-09-10 | 2020-09-14 | $2.08 | $315K | -2.0% | -33.8% | -21.7% |
| ABEO | SELL | 2020-08-17 | 2020-08-19 | $2.85 | $228K | -11.0% | -21.2% | -51.5% |
| PTBI | BUY | 2014-12-24 | 2014-12-29 | $4.00 | $1.0M | N/A | N/A | N/A |
| MACM.OB | BUY | 2007-10-10 | 2007-10-12 | $0.60 | $500K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.